IL91398A - A device for the controlled release of pneumatic substances, including the active substance, surrounded by an asymmetric membrane - Google Patents

A device for the controlled release of pneumatic substances, including the active substance, surrounded by an asymmetric membrane

Info

Publication number
IL91398A
IL91398A IL9139889A IL9139889A IL91398A IL 91398 A IL91398 A IL 91398A IL 9139889 A IL9139889 A IL 9139889A IL 9139889 A IL9139889 A IL 9139889A IL 91398 A IL91398 A IL 91398A
Authority
IL
Israel
Prior art keywords
capsule
weight
membrane
tablet
asymmetric
Prior art date
Application number
IL9139889A
Other languages
English (en)
Hebrew (he)
Other versions
IL91398A0 (en
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IL91398A0 publication Critical patent/IL91398A0/xx
Publication of IL91398A publication Critical patent/IL91398A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Executing Machine-Instructions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Materials For Medical Uses (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Saccharide Compounds (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
IL9139889A 1988-08-30 1989-08-23 A device for the controlled release of pneumatic substances, including the active substance, surrounded by an asymmetric membrane IL91398A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US23837188A 1988-08-30 1988-08-30

Publications (2)

Publication Number Publication Date
IL91398A0 IL91398A0 (en) 1990-04-29
IL91398A true IL91398A (en) 1994-05-30

Family

ID=22897578

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9139889A IL91398A (en) 1988-08-30 1989-08-23 A device for the controlled release of pneumatic substances, including the active substance, surrounded by an asymmetric membrane

Country Status (26)

Country Link
EP (1) EP0357369B1 (sh)
JP (1) JPH07112971B2 (sh)
KR (1) KR920008701B1 (sh)
CN (2) CN1058387C (sh)
AT (1) ATE89162T1 (sh)
AU (1) AU615104B2 (sh)
CA (1) CA1338552C (sh)
CZ (1) CZ277763B6 (sh)
DD (1) DD289466A5 (sh)
DE (1) DE68906488T2 (sh)
DK (1) DK175178B1 (sh)
EG (1) EG19189A (sh)
ES (1) ES2041006T3 (sh)
FI (1) FI102515B (sh)
HU (1) HU222245B1 (sh)
IE (1) IE62859B1 (sh)
IL (1) IL91398A (sh)
MX (1) MX173942B (sh)
MY (1) MY104183A (sh)
NO (1) NO179232C (sh)
NZ (1) NZ230470A (sh)
PL (1) PL163079B1 (sh)
PT (1) PT91560B (sh)
RU (2) RU1837873C (sh)
YU (1) YU47422B (sh)
ZA (1) ZA896586B (sh)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4962128A (en) * 1989-11-02 1990-10-09 Pfizer Inc. Method of treating anxiety-related disorders using sertraline
DK0542926T3 (da) * 1990-08-07 1995-05-15 Pfizer Brug af grænsefladepolymeriserede membraner i frigivelsesanordninger
DK0550641T3 (da) * 1990-09-28 1994-08-22 Pfizer Dispenseringsanordning indeholdende et hydrofobt medium
GB2267219B (en) * 1992-05-28 1996-04-03 Elan Corp Plc Differential release tablet with multiple active agents
TW235239B (sh) * 1992-11-20 1994-12-01 Pfizer
EP0670717B1 (en) * 1992-11-30 1998-11-25 Pfizer Inc. Supported liquid membrane delivery devices
US5358502A (en) * 1993-02-25 1994-10-25 Pfizer Inc PH-triggered osmotic bursting delivery devices
US5798119A (en) * 1995-06-13 1998-08-25 S. C. Johnson & Son, Inc. Osmotic-delivery devices having vapor-permeable coatings
EP0811374A1 (en) 1996-05-29 1997-12-10 Pfizer Inc. Combination dosage form comprising cetirizine and pseudoephedrine
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
SK180499A3 (en) * 1997-07-01 2001-08-06 Pfizer Sertraline salts and sustained-release dosage forms of sertraline
CA2290969C (en) * 1997-07-01 2004-02-17 Pfizer Products Inc. Delayed-release dosage forms of sertraline
DE19814256A1 (de) * 1998-03-31 1999-10-07 Asta Medica Ag Feste, schnellzerfallende Cetirizin-Formulierungen
WO2000028989A1 (en) * 1998-11-12 2000-05-25 Smithkline Beecham P.L.C. Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent
WO2000069418A1 (en) * 1999-05-17 2000-11-23 The Dow Chemical Company Process for making cellulose ether capsules with organic acids
US20030175349A1 (en) * 2001-01-30 2003-09-18 Council Of Scientific And Industrial Research Pharmaceutical compostion for extended/sustained release of a therapeutically active ingredient
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
IL164106A0 (en) 2002-04-04 2005-12-18 Pfizer Prod Inc Palatable chewable tablet
US8367111B2 (en) 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
US7611728B2 (en) * 2003-09-05 2009-11-03 Supernus Pharmaceuticals, Inc. Osmotic delivery of therapeutic compounds by solubility enhancement
US8747895B2 (en) 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
EP1802285B1 (en) 2004-10-21 2013-02-27 Aptalis Pharmatech, Inc. Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
US20060105038A1 (en) * 2004-11-12 2006-05-18 Eurand Pharmaceuticals Limited Taste-masked pharmaceutical compositions prepared by coacervation
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
US20070003624A1 (en) * 2005-06-29 2007-01-04 Shanbhag Anant R Semi-permeable compositions providing reduced drying time for osmotic dosage forms
WO2007062266A2 (en) 2005-11-28 2007-05-31 Marinus Pharmaceuticals Ganaxolone formulations and methods for the making and use thereof
EP2248541B1 (de) * 2009-05-07 2018-10-31 Biotronik Ag Medikamentenbeschichteter ballonkatheter und verfahren zur herstellung desselben
CN101773484B (zh) * 2009-05-12 2013-12-25 沈阳药科大学 胃漂浮渗透泵型非匀质膜胶囊缓控释系统及其制备方法
WO2011039686A1 (en) 2009-09-30 2011-04-07 Pfizer Inc. Latrepirdine oral sustained release dosage forms
TWI471146B (zh) 2009-12-02 2015-02-01 Aptalis Pharma Ltd 菲索特芬那定（ｆｅｘｏｆｅｎａｄｉｎｅ）微膠囊及包含其之組合物
US10898865B2 (en) * 2013-01-31 2021-01-26 American University In Cairo (AUC) Polymer-carbon nanotube nanocomposite porous membranes
JP6041823B2 (ja) 2013-03-16 2016-12-14 ファイザー・インク トファシチニブの経口持続放出剤形
WO2021014360A1 (en) 2019-07-23 2021-01-28 Pfizer Inc. Oral modified release dosage forms
AU2020385054B2 (en) 2019-11-14 2023-10-12 Pfizer Inc. 1-(((2S,3S,4S)-3-ethyl-4-fluoro-5-oxopyrrolidin-2-yl)methoxy)-7-methoxyisoquinoline-6-carboxamide combinations and oral dosage forms
WO2021156698A1 (en) 2020-02-03 2021-08-12 Johnson & Johnson Consumer Inc. A single layer chewable tablet comprising cetirizine

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL271831A (sh) * 1960-11-29
ATE10582T1 (de) * 1981-01-22 1984-12-15 Capsugel A.G. Verfahren zur herstellung pharmazeutischer, darmloeslicher kapseln.
NZ206600A (en) * 1983-05-11 1987-01-23 Alza Corp Osmotic drug delivery device
GB8322007D0 (en) * 1983-08-16 1983-09-21 Wellcome Found Pharmaceutical delivery system
US4684524A (en) * 1984-03-19 1987-08-04 Alza Corporation Rate controlled dispenser for administering beneficial agent
DE3486409T2 (de) * 1984-08-17 1996-04-25 Wellcome Found Zusammensetzung zur kontrollierten Abgabe eines Wirkstoffs.
US4837111A (en) * 1988-03-21 1989-06-06 Alza Corporation Dosage form for dispensing drug for human therapy

Also Published As

Publication number Publication date
YU47422B (sh) 1995-03-27
KR920008701B1 (ko) 1992-10-08
NO893450L (no) 1990-03-01
PL163079B1 (pl) 1994-02-28
PT91560B (pt) 1995-05-04
MY104183A (en) 1994-02-28
CA1338552C (en) 1996-08-27
FI102515B1 (fi) 1998-12-31
EP0357369A3 (en) 1991-10-02
PT91560A (pt) 1990-03-30
JPH02174713A (ja) 1990-07-06
IE62859B1 (en) 1995-03-08
YU165789A (en) 1992-05-28
DE68906488T2 (de) 1993-09-09
DE68906488D1 (de) 1993-06-17
DK424489A (da) 1990-03-01
AU4089189A (en) 1990-05-31
JPH07112971B2 (ja) 1995-12-06
ATE89162T1 (de) 1993-05-15
CN1125573A (zh) 1996-07-03
DD289466A5 (de) 1991-05-02
HUT74086A (en) 1996-11-28
NO179232B (no) 1996-05-28
ES2041006T3 (es) 1993-11-01
RU2093147C1 (ru) 1997-10-20
EP0357369B1 (en) 1993-05-12
CS501189A3 (en) 1992-12-16
DK424489D0 (da) 1989-08-29
MX173942B (es) 1994-04-11
FI894046A0 (fi) 1989-08-29
DK175178B1 (da) 2004-06-28
AU615104B2 (en) 1991-09-19
ZA896586B (en) 1991-04-24
NO179232C (no) 1996-09-04
CN1042072A (zh) 1990-05-16
NZ230470A (en) 1991-06-25
CZ277763B6 (en) 1993-04-14
FI102515B (fi) 1998-12-31
RU1837873C (ru) 1993-08-30
EG19189A (en) 1994-11-30
HU222245B1 (hu) 2003-05-28
NO893450D0 (no) 1989-08-29
CN1058387C (zh) 2000-11-15
EP0357369A2 (en) 1990-03-07
FI894046A (fi) 1990-03-01
IE892771L (en) 1990-02-28
IL91398A0 (en) 1990-04-29
KR900002821A (ko) 1990-03-23

Similar Documents

Publication Publication Date Title
US5612059A (en) Use of asymmetric membranes in delivery devices
EP0357369B1 (en) The use of asymetric membranes in delivery devices
US5178868A (en) Dosage form
US5876752A (en) Use of interfacially-polymerized membranes in delivery devices
CA2148837C (en) Delivery device having encapsulated excipients
IE61223B1 (en) Osmotic continuous dispensing oral delivery system containing a pharmaceutically acceptable active agent having improved core membrane adhesion properties
EP0365947B1 (en) Novel dosage form
ZA200500834B (en) Oral dosage form comprising a liquid active agent formulation and controlling release thereof by an expandable osmotic composition
KR100527335B1 (ko) 서방형 약물 전달 기구
JP2007520421A (ja) 経口投与用放出制御型薬物送達システム
FI102455B (fi) Menetelmä oraalisen farmaseuttisen moniyksikköformulaation valmistamis eksi

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees